ATE180967T1 - Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür - Google Patents

Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür

Info

Publication number
ATE180967T1
ATE180967T1 AT93906980T AT93906980T ATE180967T1 AT E180967 T1 ATE180967 T1 AT E180967T1 AT 93906980 T AT93906980 T AT 93906980T AT 93906980 T AT93906980 T AT 93906980T AT E180967 T1 ATE180967 T1 AT E180967T1
Authority
AT
Austria
Prior art keywords
horserad
functional disorder
preparation therefor
sinus
treating nose
Prior art date
Application number
AT93906980T
Other languages
English (en)
Inventor
William H Friedman
Original Assignee
William H Friedman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William H Friedman filed Critical William H Friedman
Application granted granted Critical
Publication of ATE180967T1 publication Critical patent/ATE180967T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT93906980T 1992-03-02 1993-02-19 Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür ATE180967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/844,107 US5248504A (en) 1992-03-02 1992-03-02 Method of treatment for nasal and sinus dysfunction

Publications (1)

Publication Number Publication Date
ATE180967T1 true ATE180967T1 (de) 1999-06-15

Family

ID=25291834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93906980T ATE180967T1 (de) 1992-03-02 1993-02-19 Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür

Country Status (8)

Country Link
US (2) US5248504A (de)
EP (1) EP0630232B1 (de)
JP (1) JPH07504436A (de)
KR (1) KR950700077A (de)
AT (1) ATE180967T1 (de)
CA (1) CA2131458A1 (de)
DE (1) DE69325265D1 (de)
WO (1) WO1993017666A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858408A (en) * 1994-07-20 1999-01-12 Toyama Chemical Co., Ltd. Sustained-release oral ointment
US5686108A (en) * 1995-09-27 1997-11-11 Amway Corporation Brassica vegetable supplement and process for manufacture
KR20010031363A (ko) * 1997-10-22 2001-04-16 젠스 포니카우 진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도
US20010053775A1 (en) * 1998-01-30 2001-12-20 Matthias Seidel Nasal solutions
US6164278A (en) * 1999-02-25 2000-12-26 Nissani; Moti Taste-based approach to the prevention of teeth clenching and grinding
US20040046440A1 (en) * 2001-12-14 2004-03-11 Daniel Brinker Knuckle hub assembly and method for making same
US6355262B1 (en) 1999-08-30 2002-03-12 Sigmund Krentz Liniment for topical application
US6596313B2 (en) 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US7166435B2 (en) 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US7396546B2 (en) * 2001-08-06 2008-07-08 The Quigley Corporation Anti-microbial compositions and methods of using same
US20040019316A1 (en) * 2002-03-13 2004-01-29 Morris John K. Nasal airway delivery, decongestion system (NADDS)
AU2003274712A1 (en) * 2002-09-25 2004-05-13 Andrea Marinello Apparatus for the treatment of maxillary and frontal sinusitis and neuritis and neuralgia of the trigeminal nerve
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
US7507425B2 (en) * 2005-09-27 2009-03-24 The Quigley Corporation Method for the treatment of cachexia
US20080038386A1 (en) * 2006-08-02 2008-02-14 Ashok K Moza Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition
EP2008530B1 (de) * 2007-06-19 2011-01-19 Symrise AG Aromakomposition zum Verringern oder Unterdrücken von unerwünschtem bitteren und adstringierenden Eindruck
GB201010418D0 (en) * 2010-06-22 2010-08-04 Univ Warwick Prevention of proteomic and genomic damage by dicarbonyl substrates of Glo1
WO2012074922A1 (en) * 2010-11-29 2012-06-07 Security Equipment Corporation Defense spray using isothiocyanate as an ingredient
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US8865772B2 (en) 2012-07-26 2014-10-21 The William M. Yarbrough Foundation Method for treating skin cancer
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US63965A (en) * 1867-04-16 Thomas l
US153933A (en) * 1874-08-11 Improvement in compounds for cough-sirup
US98875A (en) * 1870-01-18 Peter mays and price mays
US71549A (en) * 1867-11-26 Executrix
US378504A (en) * 1888-02-28 Catarrh remedy
US74205A (en) * 1868-02-11 Chaeles a
US28904A (en) * 1860-06-26 Medical compound
DE974171C (de) * 1954-02-06 1960-10-06 Rolf Opitz Verfahren zur Herstellung eines Rettichpraeparates
US3781424A (en) * 1970-07-21 1973-12-25 E Ponvert Hemorrhoid treatment preparation produced from hot cherry peppers
DE2063845A1 (de) * 1970-12-24 1972-06-29 Vujcuf, Josef, 8000 München Antidiabetisches Pflanzenpräparat
HU181559B (en) * 1980-04-28 1983-10-28 Herbaria Orszagos Gyogynoeveny Composition for promoting the growth of the hair and stimulating the hair with improved characteristics and process for its preparation
US4782023A (en) * 1984-02-03 1988-11-01 Abbott Laboratories Stabilized horseradish peroxidase conjugate composition
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
CA1321144C (en) * 1986-08-07 1993-08-10 Henrich H. Paradies Pharmaceutical preparations
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5114969A (en) * 1989-03-22 1992-05-19 American Health Foundation Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same

Also Published As

Publication number Publication date
US5248504A (en) 1993-09-28
EP0630232A1 (de) 1994-12-28
JPH07504436A (ja) 1995-05-18
KR950700077A (ko) 1995-01-16
US5385734A (en) 1995-01-31
DE69325265D1 (de) 1999-07-15
CA2131458A1 (en) 1993-09-16
EP0630232B1 (de) 1999-06-09
WO1993017666A1 (en) 1993-09-16
EP0630232A4 (de) 1995-07-12

Similar Documents

Publication Publication Date Title
DE69325265D1 (de) Verfahren zur behandlung von nasen- und nebenhöhlenfunktionsstörung und meerrettichzubereitung hierfür
EP0259440A4 (de) Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen.
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE196082T1 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69807349D1 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
ATE101648T1 (de) Expression eines tumorspezifischen antigens eines rekombinanten virusvektors sowie dessen anwendung zur versorgenden oder heilenden behandlung des entsprechenden tumors.
DK71387A (da) Terapeutisk middel til behandling af psoriasis
ATE259640T1 (de) Verwendung von matrix-metalloproteinase inhibitoren zur förderung der wundheilung
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3650620D1 (de) Behandlungsverfahren kataboler dysfunktion
ATE239468T1 (de) Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
SE9703929D0 (sv) Therapeutical use and method
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE81006T1 (de) Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.
ATE202935T1 (de) Verfahren zur behandlung von haarausfall
ATE149840T1 (de) Behandlung von leberkrebs
DE69832165D1 (de) Hgf zur behandlung von akutem nierenversagen
EP1056458A4 (de) Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties